Compare CULP & ARAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CULP | ARAY |
|---|---|---|
| Founded | 1972 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Textiles | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 43.8M | 39.3M |
| IPO Year | 1994 | 2006 |
| Metric | CULP | ARAY |
|---|---|---|
| Price | $3.41 | $0.26 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $3.50 |
| AVG Volume (30 Days) | 14.2K | ★ 1.1M |
| Earning Date | 03-11-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 47.06 | ★ 87.50 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $203,482,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $8.42 | $4.58 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.70 | $0.22 |
| 52 Week High | $4.75 | $2.10 |
| Indicator | CULP | ARAY |
|---|---|---|
| Relative Strength Index (RSI) | 50.23 | 44.41 |
| Support Level | $3.42 | $0.24 |
| Resistance Level | $3.50 | $0.34 |
| Average True Range (ATR) | 0.13 | 0.03 |
| MACD | 0.00 | -0.00 |
| Stochastic Oscillator | 60.47 | 1.30 |
Culp Inc manufactures, markets mattress fabrics for bedding and upholstery fabrics for residential, commercial, and hospitality furnishings. The company has two operating segments: Mattress fabrics, which generate maximum revenue, and Upholstery fabrics. The mattress fabrics segment manufactures, sources, and sells fabrics and mattress covers to bedding manufacturers. The upholstery fabrics segment develops, sources, manufactures, and sells fabrics to residential, commercial, and hospitality furniture manufacturers. Geographically, it derives key revenue from the United States of America.
Accuray Inc is a radiation oncology company that develops, manufactures, sells and supports precise, treatment solutions which set the standard of radiation therapy care with the objective of helping patients live lives. The company's technology, The CyberKnife, is used to treat multiple types of cancer and tumors throughout the body. The CyberKnife Systems automatically track, detect and correct for a tumor and patient movement in real-time during the procedure, enabling delivery of precise, high dose radiation with sub-millimetre accuracy while patients breathe normally, without manual user intervention.